Back to Journals » Drug Design, Development and Therapy » Volume 13
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Endostatin attenuates PDGF-BB- or TGF-β1-induced HSCs activation via suppressing RhoA/ROCK1 signal pathways
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
8,059 | Dovepress* | 7,283+ | 1,441 | 8,724 | |
PubMed Central* | 776 | 240 | 1,016 | ||
Totals | 8,059 | 1,681 | 9,740 | ||
*Since 11 January 2019 |
View citations on PubMed Central and Google Scholar